e-learning
resources
ERJ
2007
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serological test and chest computed tomography findings in patients with Mycobacterium avium complex lung disease
Kitada S., Nishiuchi Y., Hiraga T., Naka N., Hashimoto H., Yoshimura K., Miki K., Miki M., Motone M., Fujikawa T., Kobayashi K., Yano I., Maekura R.
Source:
Eur Respir J 2007; 29: 1217-1223
Journal Issue:
June
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kitada S., Nishiuchi Y., Hiraga T., Naka N., Hashimoto H., Yoshimura K., Miki K., Miki M., Motone M., Fujikawa T., Kobayashi K., Yano I., Maekura R.. Serological test and chest computed tomography findings in patients with Mycobacterium avium complex lung disease. Eur Respir J 2007; 29: 1217-1223
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Imaging of eosinophilic lung disease
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Serological test and chest computed tomography findings in patients with
mycobacterium avium-intracellulare
(MAC) lung disease
Source: Annual Congress 2007 - Diagnostic tests and treatment in non cystic fibrosis bronchiectasis
Year: 2007
Mycobacterium avium complex disease: prognostic implication of high-resolution computed tomography findings
Source: Eur Respir J 2008; 32: 147-152
Year: 2008
High-resolution computed tomography (HRCT) findings are good predictors of response to treatment in Mycobacterium avium complex (MAC) pulmonary disease
Source: Breathe 2008; 5: 180
Year: 2008
Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection
Source: Eur Respir J 2006; 28: 24-30
Year: 2006
Are interferon- gamma release assays useful for diagnosing active tuberculosis in a high-burden setting?
Source: Eur Respir J 2011; 38: 649-656
Year: 2011
The utility of a serodiagnosis for
mycobacterium avium
complex pulmonary disease diagnosed by the single available bronchial wash
Source: Eur Respir J 2004; 24: Suppl. 48, 206s
Year: 2004
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
Neutrophil-dominant inflammation is associated with severity in high-resolution computed tomography (HRCT) findings in patients with nontuberculous mycobacterium (NTM) infection
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Impact of T-SPOT.
TB
test to exclude active
Mycobacterium tuberculosis
complex infection in patients with mycobacterial disease
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2005; 26: 1092-1096
Year: 2005
Usefulness of bronchial lavage for the diagnosis of pulmonary disease caused by mycobacterium avium-intracellulare complex (MAC) infection
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003
Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-γ assay
Source: Eur Respir J 2007; 29: 1212-1216
Year: 2007
High-resolution computed tomography in Mycobacterium avium complex disease: one step forward, two steps back
Source: Eur Respir J 2008; 32: 813
Year: 2008
Clinical evaluation of anti-glycopeptidelipid core immunoglobulin A antibody assay for serodiagnosis of pulmonary
Mycobacterium avium-intracellulare
complex (MAC) disease
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005
Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOTTM.TB assay
Source: Eur Respir J 2007; 29: 605-607
Year: 2007
Susceptibility to nontuberculous mycobacterial lung disease
Source: Eur Respir J 2008; 31: 1322-1333
Year: 2008
Outcomes of
Mycobacterium avium
complex lung disease based on clinical phenotype
Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016
Year: 2017
Clinical nalysis of glycopeptidolipid core antigen IgA antibodies for cases in which it is difficult to obtain a definite diagnosis of mycobacterium avium complex pulmonary disease
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016
Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients
Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Year: 2018
Clinical analysis of pulmonary Mycobacterium avium complex disease in Japan
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept